BioCentury
ARTICLE | Clinical News

ELAD system: Completed Phase III enrollment

February 9, 2015 8:00 AM UTC

Vital completed enrollment of about 200 patients in the open-label, international Phase III VTI-208 trial to compare the ELAD system given up to 5 times in combination with standard of care (SOC) vs. ...